Blood Glucose news 2007

2007-03-03 Study Confirms That Significant Insulin Dose Errors Can Result When Blood Glucose Meters Are Miscoded

Bayer HealthCare, Diabetes Care is a worldwide leader in diabetes, supporting customers in 100 countries. Since the introduction of CLINITEST(R) reagent tablets in 1941, Bayer has led the way in diabetes care product innovation. The company changed the face of diabetes care in 1969 when it introduced the first portable blood glucose meter and test strips. Bayer HealthCare further innovated diabetes management by being the first company to introduce a suite of blood glucose monitors with No Coding(TM) technology. The BREEZE(R) and CONTOUR(R) blood glucose monitoring systems offer people with diabetes an unparalleled choice in diabetes management systems. The Arthritis Foundation in the United States and the Arthritis Society of Canada each granted Ease-of Use Commendation to the BREEZE meter, representing the

www.medicalnewstoday.com

When persons with diabetes use miscoded blood glucose meters to determine how much insulin to take, significant errors in insulin dose can result that may potentially lead to short- and lon - Diabetes news medical news health news medical headlines healthcare news health articles medicine articles welfare living

2007-06-27 Blood Glucose May Affect More Pregnancies at Portable Planet

Pregnant women who have never had diabetes before but who have high blood glucose levels during pregnancy are said to have gestational diabetes (GDM). GDM affects about 4 pct. of all pregnant women about 135,000 cases of gestational diabetes in the United States each year. GDM usually goes away after pregnancy, but chances are 2 in 3 that this condition will return in future pregnancies. In some women, however, pregnancy uncovers type 1 or type 2 diabetes. Obstetricians normally test women for GDM around the 28th week of pregnancy. Treatment for GDM involves diet and physical activity, and may also include daily blood glucose testing and insulin injections.

www.portableplanet.co.uk

Weve got the whole world in our hands - Ism 3k2 k2 redux 3k2redux ultraminima ultra minima theme wordpress Enterprise Activism Webdesign Non-Profits blog political blog headsetoptions news politics media history

2007-06-25 Hyperglycemia and adverse pregnancy outcome study (HAPO)

Pregnant women who have never had diabetes before but who have high blood glucose levels during pregnancy are said to have gestational diabetes (GDM). GDM affects about 4 pct. of all pregnant women -- about 135,000 cases of gestational diabetes in the United States each year. GDM usually goes away after pregnancy, but chances are 2 in 3 that this condition will return in future pregnancies. In some women, however, pregnancy uncovers type 1 or type 2 diabetes. Obstetricians normally test women for GDM around the 28th week of pregnancy. Treatment for GDM involves diet and physical activity, and may also include daily blood glucose testing and insulin injections.

www.news-medical.net

Gestational diabetes may place a much higher percentage of pregnant women -- and their unborn babies -- at risk for adverse outcomes than previously believed, according to a major international study presented at the American Diabetes Associations 67th Annual Scientific Sessions.

2007-06-26 Most Important Diabetes Test May Be Reported in New Units

With the introduction of the new reference method, an international consortium of investigators decided that it was an appropriate time to confirm that the A1C test truly does indicate the average blood glucose over time. Moreover, should the relationship be true, the investigators, under the auspices of the American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), and International Diabetes Federation (IDF), believe that a more easily interpretable A1C value for health care practitioners, and their patients, would be to express the test results as the "average glucose," and in units comparable to those obtained from self-monitoring. Support for the study was made possible by contributions from Abbott Diabetes Care, Bayer HealthCare, GlaxoSmithKline, LifeScan, Inc, Medtronic MiniMed,

www.earthtimes.org

CHICAGO /PRNewswire-USNewswire/ -- The preliminary results from an international study showing the relationship between hemoglobin A1c (A1C) levels and average blood glucose levels, were. - Glucose a1c diabetes blood study average results new levels international type units test association reference using their american method relationship insulin months patients

2007-06-28 Diabetech and reg; Presents Type 2 Diabetes Clinical Trial Results at ADA Scientific Sessions

Following enrollment and establishment of the patients profile, patient participants were given Diabetechs market leading GlucoMON and reg; wireless glucose meter for automated and accurate blood glucose data collection, automated GlucoDYNAMIX blood glucose logbooks from their online personal health record (PHR), QuickTips lifestyle and diabetes educational messages, HomeCheck hematology screening and A1c laboratory tests at enrollment and every 90 days thereafter, activity guides and more. Minimal human intervention from program staff and practitioners in this trial also demonstrates the efficiencies gained using automated technology instead of weekly phone calls from highly skilled professionals who are also in limited supply.

www.prweb.com

PR: Diabetechs healthcordia Intensive Management Programs combine mobile diagnostic devices, rules engine technology and social networks to deliver significant outcomes in type 2 diabetes patients. Chicago, IL (PRWEB) - Diabetech, LP, a proven leader and pioneer in extending diabete

2007-06-07 Abbott Receives European CE Mark Approval for FreeStyle Navigator(R) Continuous Glucose Monitoring System

The FreeStyle Navigator System is designed to discreetly measure glucose levels once per minute without the recurring pain and hassle that can accompany conventional blood glucose testing. With early warning alarms that alert the patient to potential highs and lows, and by providing glucose information once per minute (equivalent to 1440 times per day), the FreeStyle Navigator system provides a more complete picture of where the persons glucose level is, and where it is going -- up or down. For people with diabetes, less time spent in either a hypoglycemic (low blood sugar) or hyperglycemic (high blood sugar) state has been correlated with better diabetes management and reduced risk for a number of serious short- and long-term diabetes-related complications(1).

www.prnewswire.co.uk

2007-11-28 Abchurch Communications Ltd :: Mercury Therapeutics, Inc. : Breakthrough for Patients With Type-2 Diabetes

Mercury Therapeutics, Inc. : Breakthrough for Patients With Type-2 Diabetes

In T2DM, a build-up of lipid within skeletal muscle suppresses the muscle cells ability to take in glucose from the blood when stimulated to do so by insulin (termed insulin resistance), resulting in elevated blood glucose levels. The spillover of glucose is taken up by the liver for triglyceride synthesis, thereby contributing to the higher plasma triglycerides and lower HDL levels associated with insulin resistance. In addition the higher blood glucose levels evoke pancreatic beta cell insulin secretion that sustained over time contributes to the development of beta cell failure. A direct small molecule activator of AMPK that works independently of insulin levels has been shown in published reports to reduce insulin resistance in skeletal muscles of rat and mice models of T2DM, along with reductions in blood glucose,

sev.prnewswire.com

Mercury Therapeutics, Inc. (MTI) has developed a novel lead generation platform to identify small molecule activators of protein kinases involved in the regulation of energy metabolism. The technology employed is in an interrelated series of in-vitro and cell-based protein kinase and cell metabolism assays that allow for the rapid filtering of the numerous hits that are routinely identified in

2007-01-19 Taking Blood Cells for a Spin -- Simpson 2007 (118): 3 -- ScienceNOW

The goal is to purify plasma, the fluid that transports vital substances, such as blood cells, carbon dioxide, glucose, and vitamins. Many medical tests require samples of plasma without components like red and white blood cells, including those for cholesterol and glucose levels and immune deficiencies. Smaller and easier-to-use machines for blood separation have begun to replace older ones such as the spinning centrifuge. Because they require less blood, these tests are easier for patients. In addition, these so-called microfluidic devices differ from other separators because they contain no moving parts, which could increase reliability.

sciencenow.sciencemag.org

2007-11-22 The Princess and the Pancreas: A Fable About Type 1 Diabetes - Diabetes Health

This is a blood test to see if you have diabetes. First, you fast (no food. ) for about eight hours. Then a little bit of blood taken from a small vein and is put into a little test tube. Off it goes to a laboratory, where the amount of glucose in the blood is measured. A person who does not have diabetes will have under 100 mg/dl (milligrams of glucose in a deciliter of blood). A person who has diabetes will have 126 mg/dl or more. The test is repeated if the number is high, just to make sure that everything was done correctly and that the high number is not just a fluke.

www.diabeteshealth.com

Diabetes Health - Newsrooms: Type 1. Type 1 diabetes, type 2 diabetes, diabetes causes, diabetes treatments and medication, celebrities with diabetes. Diabetes news articles, videos, blogs and more.

2007-12-30 Counter TS Test Strip Recall Issued After Bayer Diabetes Care Reports Manufacturing Issue

When people with diabetes can control their blood sugar (glucose), they are more likely to stay healthy. People with diabetes use two kinds of management devices: Glucose meters and other diabetes management tests. Glucose meterswhich use glucose test stripshelp enable people with diabetes to check their blood sugar at home, school, work, and play. As a general rule, the American Diabetes Association (ADA) recommends that most patients with Type 1 diabetes test their glucose three or more times per day. Pregnant women taking insulin for gestational diabetes should test two times per day. ADA does not specify how often people with type 2 diabetes should test their glucose, but testing often helps control the disease.

www.newsinferno.com